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Aims: Mineralo-organic nanoparticles (NPs) detected in biological fluids have been 
described as precursors of physiological and pathological calcifications in the body. 
Our main objective was to examine the early stages of mineral NP formation in 
body fluids. Materials & methods: A nanomaterial approach based on atomic force 
microscopy, dynamic light scattering, electron microscopy and spectroscopy was used. 
Results: The mineral particles, which contain the serum proteins albumin and fetuin-A, 
initially precipitate in the form of round amorphous NPs that gradually grow in size, 
aggregate and coalesce to form crystalline mineral films similar to the structures 
observed in calcified human arteries. Conclusion: Our study reveals the early stages of 
particle formation and provides a platform to analyze the role(s) of mineralo-organic 
NPs in human tissues.
Keywords: biological fluids • biomineralization • calcium granules • carbonate apatite  
• ectopic calcification • mineral biofilms • mineral particles • mineralo-organic interface 
Ectopic calcification is found in various 
human conditions, including aging, athero-
sclerosis, cancer, chronic kidney disease and 
Type 2 diabetes [1,2]. The presence of vascu-
lar calcification correlates with the progres-
sion of cardiovascular disease in humans [2], 
and people with signs of vascular calcifica-
tion display increased morbidity and mor-
tality risks [2,3]. These observations suggest 
that ectopic calcification is detrimental to 
human health. Yet the mechanisms regulat-
ing ectopic calcification and the formation 
of calcified deposits remain incompletely 
understood.
Ectopic calcification in vascular tissues is 
believed to be initiated by cells that differ-
entiate into osteoblast-like cells and initiate 
bone formation in response to inflammation 
or excess calcium and phosphate ions [4,5]. 
Osteoblast-like cells found in vascular tissues 
release lipid-bound vesicles, which resemble 
the matrix vesicles that induce mineraliza-
tion in developing bones [4,5]. Matrix vesicles 
may concentrate calcium and phosphate 
ions through the action of transporters and 
enzymes that release phosphate ions from 
organic compounds. A core of calcium phos-
phate similar to the mineral found in bones 
and teeth forms inside matrix vesicles and 
is eventually released in the surrounding 
medium to initiate calcification. While prog-
ress has been made in our understanding of 
vascular calcification, the mechanism of 
formation of calcified deposits in biological 
fluids remains unclear.
Several studies have reported the detec-
tion of amorphous mineral particles in 
developing bones and teeth of vertebrates. 
Höhling et al. [6] and Robinson [7] have 
observed that round mineral nanoparticles 
(NPs) represent the first mineral depos-
ited in developing bones and teeth. Similar 
mineral NPs have been detected in ecto-
pic calcifications found in soft tissues. For 
instance, Jahnen-Dechent and colleagues 
have detected fetuin-A-containing calcium 
phosphate complexes, which this group 
called ‘calciprotein particles,’ in ascitic 
fluids of calcifying peritonitis patients [8]. 
This group showed that fetuin-A and acidic 
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Figure 1. Atomic force microscopy observations of mineralo-organic nanoparticles formed in biological fluids. 
Mineralo-organic NPs were prepared by adding 10 mM CaCl2 and NaH2PO4 each into DMEM containing 10% 
FBS, followed by incubation under cell culture conditions for (A) 2, (B) 11 and (C) 21 days. Note that the particles 
increase in size in a time-dependent manner and some appear to fuse during incubation (in C, arrows denote 
particle fusion lines).
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serum proteins participate in the formation and 
stabilization of the calcium phosphate complexes, 
which may transform with time from small spheres 
to large prolate ellipsoid (i.e., ‘secondary calciprotein 
particles’) [8]. A recent study by Bertazzo et al. con-
firmed the presence of mineral NPs in aortic valves 
and coronary arteries of both atherosclerotic and 
rheumatic fever patients [9]. The possibility that such 
mineral NPs may represent precursors of mineral 
structures formed in animals and humans remains to 
be examined.
Our previous studies have shown that mineralo-
organic NPs spontaneously form in human and ani-
mal body fluids incubated under cell culture con-
ditions [10–23]. These mineralo-organic NPs have 
helped us to resolve a major controversy concerning 
the existence of the so-called nanobacteria (NB) – 
mineralized entities initially described as the smallest 
microorganisms on earth [24] and as the possible cause 
of various human diseases, including atherosclerosis, 
cancer, kidney stones, polycystic kidney disease and 
prostatitis [25–27]. Our work has shown that NB actu-
ally represent nonliving mineral NPs that mimic liv-
ing microorganisms in terms of their shape, growth, 
proliferation and subculture [11,18]. Mineralo-organic 
NPs similar to NB have been shown to form not only 
in human body fluids but also in various organs of 
the human body, including in the lungs, blood ves-
sels, kidneys and bones (see [22] for a review of the fac-
tors controlling particle formation in the body). The 
possibility that these mineralo-organic NPs may play 
a role in human diseases is currently under intensive 
investigation.
We observed earlier that mineralo-organic NPs 
grow in size and number in biological fluids, forming 
mineralized structures resembling platelets, spindles 
and eventually biofilms [11–13]. In the present work, 
we used a nanomaterial approach to follow the ini-
tial stages of particle formation as well as their trans-
formation from amorphous structures to crystalline 
minerals. We also examined the location of organic 
molecules within the mineral particles using immu-
nogold labeling and electron microscopy. These 
results provide important insights for understanding 
the formation of ectopic calcification occurring in the 
human body.
Materials & methods
Preparation of mineralo-organic NPs
Human serum (HS) was obtained from healthy vol-
unteers as previously described [11]. The use of human 
samples was approved by the Institutional Review 
Board of Chang Gung Memorial Hospital (Linkou, 
Taiwan). Written informed consent was obtained 
from the volunteers. HS-NPs were obtained by add-







co’s modified Eagle’s medium (DMEM; Gibco, CA, 
USA) containing 0.1–10% HS. The resulting solu-
tion was incubated under cell culture conditions in 
an incubator (37°C, 5% CO
2
, humidified air) for the 
time indicated. HS-NPs were pelleted by centrifuga-
tion at 16,000 × g for 15 min at 4°C prior to two 
washing steps using HEPES buffer (20 mM HEPES, 
1 mM CaCl
2




, 150 mM NaCl) 
and the same centrifugation conditions. Particles 







 each into DMEM containing 0.1–10% 
fetal bovine serum (FBS; Biological industries, Kib-
butz Beik Haemek, Isreal), before incubation in cell 
culture conditions for the time indicated. All ion 
solutions were adjusted to pH 7.4 and sterilized by 
filtration through 0.2 μm membranes prior to use.
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Figure 2. Atomic force microscopy observations and 3D surface profiles of mineralo-organic nanoparticle 
specimens. Mineralo-organic NPs prepared as in Figure 1 were observed by atomic force microscopy, either 
immediately after mixing precipitating ions at ‘Time 0’ (A) or after incubation in cell culture conditions for 7 days 
(B & C). The corresponding 3D surface profiles are shown (D–F). The particles grow in size, fuse and aggregate 
with time.
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Atomic force microscopy
One drop of particle solution was deposited onto a 
glass slide, and the sample was air-dried prior to obser-
vation under a multimode scanning probe atomic 
force microscope equipped with a NanoScope IV con-
troller (Veeco, NY, USA). Observations were made at 
a scan rate of 2 Hz using a resolution of 512 lines per 
sample.
Dynamic light scattering measurements
Dynamic light scattering (DLS) measurements were 
performed with a Coulter N4 Plus submicron-parti-
cle size analyzer (Beckman Coulter, CA, USA). The 
samples were transferred to disposable plastic cuvettes 
(Kartell, Milan, Italy) and mixed by gentle inversion. 
Measurements were performed in triplicate at 25°C at 
an incident angle of 90°.
Transmission & scanning electron microscopy
Washed NPs were deposited onto nickel grids (Elec-
tron Microscopy Sciences, PA, USA), and excess liq-
uid was removed by using absorbent paper. The grids 
were dried overnight under a digital desiccator. The 
samples were visualized without fixation or staining 
under a JEM 1230 transmission electron microscope 
(JEOL, Tokyo, Japan) operated at 100 keV. Control 
hydroxyapatite (HAP) consisted of a buffered aqueous 
suspension (25% solid; Sigma, MI, USA).
For scanning electron microscopy (SEM), washed 
and dried samples prepared as above were coated 
with gold for 90 s. The specimens were observed 
with a field-emission SEM S-5000 scanning electron 
microscope (Hitachi Science Systems, Tokyo, Japan).
For thin-section transmission electron microscopy 
(TEM), washed HS-NPs obtained as above were fixed 
for 4 h with a solution of 2.5% glutaraldehyde and 
1% paraformaldehyde in ddH
2
O at 4°C. The particles 
were washed three-times with ddH
2
O for 10 min each 
time. Pellets containing the particles were dehydrated 
with successive incubations into 30, 50, 70, 80, 90, 
95 and 100% ethanol, for 10 min each time. When 
ethanol at 70% was used, the particle pellets were 
incubated at 4°C overnight. The other ethanol solu-
tions were only incubated with the pellets for 10 min. 
Dehydrated particle pellets were incubated with LR 
white-embedding medium (Electron Microscopy Sci-
ences). Various ratios of ethanol and LR medium (3:1, 
1:1 and 1:3) were used for 30 min each. Particle pellets 
were treated with fresh LR medium (100%) overnight 
before polymerization. Pellets were incubated at 60°C 
for 2 days to allow polymerization to occur. Blocks 
of NP samples were sectioned by using a Leica Ultra-
cut UCT microtome. Sections were stained with 4% 
uranyl acetate before observation as described above. 
Electron diffraction patterns were acquired under the 
same conditions.
Time 0 Day 7 Day 7
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Figure 3. Dynamic light scattering measurements of particle size and number during incubation in biological 
fluids. (A & B) Mineralo-organic NPs were prepared by adding 0.7 mM CaCl2 and NaH2PO4 each into DMEM 
containing FBS at the final concentrations indicated, followed by incubation under cell culture conditions. Particle 
size (A) and number (B) were determined using DLS. (C & D) A similar analysis was performed for particles 
prepared in HS-DMEM. In (B) and (D), the bars and error bars which are masked by other bars of the graph 
correspond to the following relative particle unit values: 2.0 × 105 ± 0.7 × 105 for 10% FBS, 3 days;  
2.5 × 105 ± 0.3 × 105 for 10% HS, 3 days; and 0.8 × 105 ± 0.4 × 105 for 0.3% HS, 1 day.
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Production of polyclonal antibodies
Five hundred micrograms of either albumin or fetuin-A 
(Sigma) were dissolved into DMEM prior to mixing 1:1 
with Freund’s complete adjuvant (Sigma). Mixing was 
performed with two syringes fixed by a 3-way stopcock 
(Nipro Diagnostics, FL, USA). Solutions were injected 
intradermally in 3-month-old New Zealand white rab-
bits. Three weeks after immunization, four boosters 
(200 μg of protein mixed with a 1:1 solution of DMEM 
and incomplete Freund’s adjuvant) were injected at a 
1-month interval. Venous blood was collected from the 
ear vein. For apo-A1, 30-kDa SDS-PAGE bands corre-
sponding to 200 μg of protein from whole serum were 
used for injections as described above.
Immunogold staining
Mineralo-organic particles were prepared as for TEM 
observation. HS-NPs embedded in resin were cut into 
slices of <70-nm thickness. Samples deposited on grids 
were blocked with 1% fish gelatin (Sigma) in 0.1 M 
HEPES buffer at pH 8.0 for 30 min. Grids were incu-
bated with anti-human serum albumin (α-HSA; 1:30), 
anti-human serum fetuin-A (α-HSF; 1:50–1:70), anti-
apolipoprotein-A1 (α-apo-A1; 1:30) and anti-HS-
NP (α-HS-NP; 1:60) antibodies. Negative controls 
received no primary antibody. Sections were washed 
with HEPES buffer for 15 min. Washed samples were 
blocked with 1% fish gelatin in HEPES buffer for 






























































































































Figure 4. Electron microscopy observations of mineralo-organic nanoparticles during incubation in cell culture. 
Mineralo-organic NPs derived from FBS-DMEM as described in Figure 1 were prepared for TEM without fixation, 
embedding or staining (A–D) and for SEM (E–H) immediately after precipitation (time 0) or following incubation 
in cell culture conditions for 1, 7 and 14 days as indicated. Initially, round and distinct following precipitation 
(time 0), mineral particles gradually fused and aggregated with time (day 1), eventually forming mineralized 
biofilm-like structures (days 7 and 14).
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5-nm-gold-conjugate goat anti-rabbit IgG (1:20–1:60) 
for 1 h. Specimens were washed with HEPES buffer 
and ddH
2
O for 10 min each. TEM observations were 
done as described above.
Energy-dispersive X-ray analysis
NP specimens were prepared as for thin-section TEM 
observation without staining. Energy-dispersive X-ray 
(EDX) spectra were obtained with a high-resolution 
JEM 2100 transmission electron microscope (JEOL) 
operated at 120 keV. EDX spectra were acquired in 
triplicate using an INCA Energy EDS system (Oxford 
Instruments, UK).
Powder X-ray diffraction analysis
Washed particle samples were resuspended in ddH
2
O 
and deposited on glass slides for dried overnight under 
a laminar flow hood. X-ray diffraction (XRD) analysis 
was performed by using a Bruker AXS D5005 X-ray 
diffractometer (Bruker, WI, USA). Spectra were com-
pared with the database of the Joint Committee on 
Powder Diffraction and Standard for chemical formula 
identification.
Results
Formation of mineralo-organic NPs in 
biological fluids
To characterize the development of mineral par-
ticles in biological fluids, we first prepared mineralo-
organic NPs by adding calcium and phosphate ions to 
cell culture medium (e.g., DMEM) containing FBS. 
We described this precipitation method earlier [11] to 
study mineralo-organic NPs similar to the mineral 
particles detected in human tissues [8] and to the so-
called NB [24–27]. We also studied earlier in detail the 
main factors that influence particle formation, includ-
ing pH, temperature and ion and serum concentra-
tions [11–13]. In the present study, we first observed the 
NP samples under atomic force microscopy (AFM) in 
order to visualize the mineralization process occurring 
at the nanoscale (<100 nm).
The mineral particles were observed at various times 
during incubation in cell culture (Figure 1A–C). Two 
days after precipitation, the mineralo-organic NPs 
consisted of spherical or ovoidal particles ranging 
from 50 to 250 nm in diameter (Figure 1A). Particle 
size gradually increased during incubation (Figure 1B, 
11 days), eventually reaching sizes of approximately 
100–350 nm after 3 weeks (Figure 1C). With time, 
the particles fused and formed larger mineral aggre-
gates, as seen by the presence of fusion lines in adjacent 
particles (Figure 1C, arrows).
In order to observe the initial stages of particle forma-
tion, we examined particle specimens immediately fol-
lowing precipitation (Figure 2A). Mineral particles that 
had just formed were of relatively small size, ranging 
between 25 and 100 nm in diameter (Figure 2A). The 
smallest particles had a poorly defined border (Figure 2A), 
compared with mature particles (Figure 2B & C, 1 week). 
The corresponding 3D surface diagrams confirmed that 
the particles increased in size and coalesced to form 
larger mineral aggregates (Figure 2D vs E & F). After 1 
week of incubation, large mineral aggregates that had 
fused together were observed (Figure 2B, C, E & F). These 
Time 0 Day 1 Day 7 Day 14
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Figure 5. Morphologies of mineralo-organic nanoparticles during incubation in culture (see facing page). 
Mineralo-organic NPs were prepared by adding CaCl2 and Na2HPO4 at 3 mM each into DMEM containing either 1% 
FBS (A–F) or 10% HS (G–L) prior to incubation under cell culture conditions for 1 month. After incubation, FBS-
NPs and HS-NPs were harvested and prepared for thin-section TEM. In samples prepared from either FBS or HS, 
mineral NPs formed rings, spindles, aggregates and films. Ring structures showed a hollow cavity while spindles 
were solid and fully mineralized. Collapsed aggregates showed a mineralized surface with longer crystalline 
projections compared with spindles. Mineralized films contained large (F) or small voids (L), depending on the 
samples examined.
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observations suggest that mineralo-organic NPs initially 
form through an amorphous liquid-like precursor that 
gradually increases in size and coalesces with time to 
form larger mineral precipitates.
Measurements of particle size & number in 
culture
To confirm the increase in size observed under AFM, 
we monitored particle size in liquid samples using 
DLS. Particles obtained after addition of precipitating 
ions in DMEM containing no FBS measured 0.7 μm 
in size and increased to 2.4 μm after 24 h of incuba-
tion (Figure 3A, 0% FBS). Particle size decreased in a 
dose-dependent manner following addition of FBS 
(Figure 3A, 0.1–10% FBS), consistent with the presence 
of calcification inhibitors such as albumin and fetuin-
A in serum [11,14,28–31]. Some particles such as the ones 
produced with 0.3 and 1% FBS did not grow with time 
and even appeared to slightly decrease in size during the 
first 24 h of incubation (Figure 3A). Solutions contain-
ing 10% FBS produced mineral NPs smaller than 100 
nm, and the particles grew slowly during the first 24 h, 
remaining stable thereafter (Figure 3A).
We also quantified the proliferation of particles incu-
bated in biological fluids using DLS. The number of 
particles in DMEM containing no FBS increased after 
precipitation before decreasing to low levels at days 1 
and 3 (Figure 3B, 0% FBS). In contrast, particle number 
obtained in the presence of FBS gradually increased for 
the first 24 h (Figure 3B, 0.1–10% FBS). Addition of FBS 
from 0 to 0.3% increased the particle number in a dose-
dependent manner, while the addition of FBS above 
this concentration produced a dose-dependent decrease 
in the number of particles (Figure 3B). Similar results 
were obtained for HS-NPs, although HS promoted 
production of larger particles (Figure 3C & D), consistent 
with the high calcification inhibitory effect of FBS com-
pared with HS [11]. These observations are in agreement 
with the seeding-inhibition concept described in previ-
ous studies [11,13]. According to this model, serum used 
at low concentrations can seed mineral particles while 
high concentrations inhibit particle formation.
Electron microscopy observations of mineral 
particle-to-film conversion
We next observed the morphology of mineralo-organic 
particles under TEM without fixation or staining 
(Figure 4A–D). Upon formation, mineralo-organic 
NPs appeared as small round particles that were either 
dispersed or forming aggregates (Figure 4A). During 
incubation in biological fluids, the particles gradu-
ally increased in size and tended to aggregate further 
(Figure 4B). Strings of particles were also observed 
(Figure 4B), consistent with the fusion of particles 
observed earlier (Figure 1C) or the possibility that the 
particles may serve as nucleators for particle forma-
tion by secondary nucleation. With time, the particles 
gradually crystallized and coalesced (Figure 4C) to form 
crystalline mineral films (Figure 4D). Observations by 
SEM confirmed the phenomenon of particle-to-film 
conversion as seen by the gradual increase in the size 
and number of the particles, until they formed film-like 
structures (Figure 4E–H).
We also prepared thin sections of the mineralo-
organic NPs for observation by TEM (Figure 5A–L). 
In samples of mineralo-organic NPs prepared in FBS 
(FBS-NPs), we initially observed half-ring and full-ring 
particles (Figure 5A & B). These particles evolved to form 
multilamellar rings (Figure 5C), before crystallizing fur-
ther into spindles (Figure 5D). The particles then gradu-
ally coalesced and aggregated (Figure 5E) to form mineral 
films (Figure 5F). Similar results were obtained when the 
particles were prepared in HS (Figure 5G–L, HS-NPs). 
However, the HS-NPs shown here were prepared using 
10% HS instead of 1% FBS for FBS-NPs, confirming 
our previous observations that FBS produced smaller 
particles compared with HS (Figure 3). Using various 
electron microscopy techniques, we thus show here 
that mineralo-organic NPs undergo a particle-to-film 
conversion in biological fluids.
Ultrastructural localization of calcification 
inhibitors in mineralo-organic NPs
We observed previously that albumin and fetuin-
A constantly interact with mineralo-organic NPs 
formed in various human body fluids including 
serum [11–13]. In order to determine the location of 
these proteins within mineralo-organic NPs and their 
possible mode of interaction with the mineral phase, 
we used immunogold labeling coupled with thin-
section TEM. In order to maximize the detection of 
mineralo-organic NPs, we prepared rabbit polyclonal 
antibodies against mineral particles that had formed 
in the presence of albumin and fetuin-A. We verified 
3526 Nanomedicine (Lond.) (2015) 10(24) future science group
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Figure 6. Immunogold staining of fetal bovine serum-nanoparticles incubated in body fluids (see facing page). 
Mineralo-organic NPs were prepared as in Figure 5, using FBS at 1%. After incubation in cell culture conditions for 
1 month, the particles were prepared for thin-section TEM and immunogold staining (A–F). Thin sections were 
treated with primary antibodies against fetuin-A (G–L) or albumin (M–R). The secondary antibody alone was used 
as negative control (‘unstained’ column). Arrows denote gold NPs bound to mineral particles. Every evolution 
stage of mineralization stained positively with the gold-conjugate antibodies directed against either BSF or BSA. 
Staining was observed mainly in the electron-dense phase of the particles and films. In the case of ring structures, 
both the surface and the inner cavities of the particles were stained with the gold-conjugated antibodies.
future science group
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earlier the antibodies’ specificity using Western blot-
ting (see [32] for experiments showing the specificity 
of the antibodies against human proteins; similar 
results were obtained for the corresponding bovine 
antibodies against bovine proteins; data not shown).
Using the polyclonal antibodies directed against par-
ticles prepared in FBS, we observed that albumin and 
fetuin-A were associated with every growth stage of the 
mineral particles (Figure 6G–R, unstained particles are 
shown in Figure 6A–F). In half-ring samples, albumin 
and fetuin-A appeared to be concentrated on the sur-
face of the particles (Figure 6G & M), while later parti-
cle stages showed proteins situated both on the surface 
and inside the mineral particles (Figure 6H–L & N–R). 
In late stages, the two serum proteins appeared to be 
associated mainly with the dark areas of the miner-
alo-organic particles (Figure 6I–L & O–R), indicating 
that this zone may contain larger amounts of organic 
molecules, compared with electron-lucent areas. Simi-
lar results were obtained for particles prepared in HS 
(Figure 7, HS-NPs).
Spectroscopy analysis of mineralo-organic NPs
We next studied the chemical composition and crys-
tallographic properties of the mineralo-organic par-
ticles formed in body fluids. Using EDX, we observed 
major peaks of carbon (C), calcium (Ca), oxygen 
(O) and phosphorus (P) in the spectra of the parti-
cles (Figure 8G & N). Minor peaks corresponding to 
sodium (Na), zinc (Zn), silicon (Si) and nickel (Ni) 
were also observed (Figure 8G & N, note that the pres-
ence of Ni may be due at least in part to the grids 
used as a support for this analysis). This EDX profile 
was consistent with the presence of calcium phos-
phate within the mineral particles. The Ca/P atomic 
ratios of the representative FBS-NP and HS-NP 
samples shown here were 1.47 and 1.15, respectively 
(Figure 8G & N). These values are similar to the theo-
retical value of 1.67 for pure, stoichiometric HAP [11], 
the crystal found in bones and teeth of vertebrates [33]. 
As described earlier [11], the minor variability of the 
Ca/P ratios measured for mineralo-organic NPs could 
be attributed to incomplete crystallization or the pres-
ence of impurities and ion substitutions within crystal 
lattices.
We used selected area electron diffraction analy-
sis (SAED) and compared the diffraction patterns 
obtained for the various growth stages. Mineralo-
organic NPs collected immediately after precipita-
tion showed a pattern of poorly crystallized mineral 
(Figure 8A & B, note that concentric rings are barely 
visible on the patterns in the insets), while particles 
cultured in biological fluids for several days produced 
polycrystalline diffraction patterns (Figure 8C–F, rings 
can be clearly observed on these patterns). Similar 
results were obtained for particles prepared in HS 
(Figure 8H–M). FBS-NPs and HS-NPs showed dif-
fraction patterns consistent with the presence of a 
polycrystalline material of relatively small crystal size, 
whereas commercial HAP used as control produced 
a pattern representing single crystals of large size 
(Figure 9A & B vs C). Besides, interplanar d-spacing 
values of the d
(002)
 reflection calculated for HS-NPs 
and FBS-NPs (i.e., 0.340 and 0.346 nm, respectively) 
were similar to that of HAP (0.348 nm), thus sug-
gesting that the mineral phase observed for these NPs 
may represent HAP.
We also used powder XRD analysis in order to study 
the development of mineralo-organic NP samples 
during incubation under cell culture conditions 
(Figure 10). We observed that mineralo-organic NPs 
were initially amorphous following precipitation 
(Figure 10A), but eventually crystallized during incu-
bation to form calcium phosphate (Figure 10B) and 
HAP crystals (Figure 10C & D). Based on these results, 
we conclude that mineralo-organic particles form 
from a poorly crystallized calcium phosphate mineral 
precursor of small size that gradually converts with 
time into crystalline HAP.
Discussion
While ectopic calcification is associated with numerous 
human diseases, the factors that induce the formation 
of calcified deposits in biological fluids remain poorly 
understood. In the present study, we show that mineral 
NPs that form in biological fluids gradually develop 
into a mineralized biofilm-like structure during incuba-
tion in cell culture conditions. This mineral biofilm-
like structure is similar to the calcified deposits found 
in human arteries and other tissues, and we therefore 
believe that the particle-to-film progression described 
here may serve as a model for studying the factors that 
induce ectopic calcification in vivo. For instance, the 
development of mineral biofilms may be used as an 
3528 Nanomedicine (Lond.) (2015) 10(24) future science group
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Figure 7. Immunogold staining of human serum-nanoparticles incubated in body fluids (see facing page). 
Mineralo-organic NPs were prepared as in Figure 5, using 10% of HS. Following incubation, the particles were 
prepared for thin-section TEM and immunostaining. The samples were treated with anti-fetuin-A antibody (G–L) 
or anti-albumin antibody (M–R). The secondary antibody alone was used as a negative control (A–F). Arrows 
denote gold NPs. As seen for FBS-NPs in Figure 6, all mineralization stages stained positively with gold-conjugate 
antibodies directed against either BSF or BSA. Gold particles were noted mainly within the electron-dense phase 
of the particles and films. Both the surface and the inner cavities of the ring structures were stained with the 
gold-conjugated antibodies.
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assay to screen for possible compounds that can inhibit 
the formation of mineral biofilms. These experiments 
may prove helpful for developing treatments that can 
prevent ectopic calcification and formation of kidney 
stones.
Our results support the notion that mineralo-organic 
NPs represent precursors of mineralization in the human 
body. These NPs have been repeatedly detected in both 
physiological and pathological calcification processes in 
vivo (reviewed in [22]). Protective mechanisms may be at 
work in vivo to limit the formation and crystallization 
of these particles in soft tissues in the healthy state. For 
instance, calcification inhibitors such as pyrophosphate 
or proteins like albumin, fetuin-A, matrix gla protein 
and osteopontin, may prevent the precipitation of cal-
cium phosphate in body fluids [34,35]. In addition, mac-
rophages of the reticuloendothelial system are believed 
to continually remove these mineral particles from cir-
culation. Accordingly, Jahnen-Dechent and colleagues 
showed that mice deficient for fetuin-A show micro-
scopic calcification when fed a mineral-rich diet [36]. 
In addition, it was shown that mineralo-organic NPs, 
which this group refers as ‘calciprotein particles,’ are 
rapidly removed from the circulation by macrophages 
of the spleen and liver following intravenous inocula-
tion in mice [37]. The recognition that mineral NPs rep-
resent the first stage of calcification may eventually help 
us to better recognize and prevent this condition, before 
macroscopic-calcified deposits are detected in the body.
Formation of mineral biofilms requires the presence 
of an amorphous mineral phase which appears to pos-
sess characteristics similar to a liquid phase. The pro-
gression from amorphous mineral to a crystalline phase 
has attracted considerable attention in recent years, and 
the amorphous mineral phase is now recognized to be 
involved in the formation of various biomineralization 
processes [38–40]. We observed that minerals that precip-
itate in the presence of organics form round amorphous 
mineral particles that possess biomimetic properties 
and undergo an amorphous-to-crystalline transition. 
We referred to these particles as ‘bions’ to denote the 
various ions that can contribute to their composition 
as well as the biological nature of the particles [20]. It 
should be noted that our use of the term bions is differ-
ent from that of Reich who coined the term in the late 
1930s to describe putative living or preliving vesicles 
isolated from decaying grass, soil and animal matter [41] 
(these findings have to our knowledge never been repro-
duced in any major scientific journal). Further studies 
are currently under way to determine the possible role 
of amorphous minerals and bions in biomineraliza-
tion processes including bone formation and ectopic 
calcification.
Our results show that mineralo-organic NPs can 
form round multi-ring particles. These multi-ring 
particles continually form alternating electron-dense 
and electron-pervious layers. Amos et al. [42] produced 
similar multi-ring mineral particles in vitro by induc-
ing mineral precipitation in the presence of anionic 
polypeptide additives. Evan et al. [43] and Ryall [44] 
have proposed that the electron-dense layers of mul-
tilamellar particles observed in human kidney tissues 
may represent organics, while the electron-pervious lay-
ers may correspond to minerals. Consistent with these 
results, we observed in the present study that albumin 
and fetuin-A are mainly located in dark, electron-dense 
layers of the particles. Previous studies performed by 
us [11–13,16] and others [8,28–31,34–36,45] have shown that 
albumin and fetuin-A are consistently associated with 
calcium phosphate mineral particles and that these 
proteins favor the formation of spherical, amorphous 
NPs. These observations and the identification of the 
proteins found in the electron-dense layers of the NPs 
may facilitate the identification of mineral particles in 
human tissues.
Another area of interest is the study of the interac-
tions between the mineralo-organic NPs described here 
and cells found in the human body. We have shown 
earlier [19] that mineralo-organic NPs are internalized 
by human macrophages and that large particles or par-
ticle aggregates with a diameter above 1 μm induce the 
secretion of pro-inflammatory IL-1β by these cells. We 
also reported that mineralo-organic particles activate 
the release of neutrophil extracellular traps (NETs) 
and that the NETs released by neutrophils may in 
turn induce the secretion of TNF-α by bystander 
macrophages [P eng HH  et al . M ineralo-organic particles 
induce innate immunity through neutrophil extracellular 
traps containing hmgb1  (2015) , S ubmitted ]. A recent study 
by Chen et al. [46] also showed that calcium phosphate 
NPs similar to the ones described in the present study 
induce the differentiation of rat bone marrow stromal 
cells into osteoblast-like cells. Besides, interactions 
between mineralo-organic NPs and the extracellular 
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Figure 8.  Selected area electron diffraction analysis of mineralo-organic nanoparticles prepared in serum 
(see also facing page). Mineralo-organic NPs were prepared as in Figure 5, using either 1% FBS (A–G) or 10% 
HS (H–N). Following incubation, the particles were prepared for thin-section TEM and SAED analysis. Electron 
diffraction patterns (insets at the top right of each TEM image) revealed that the forming particles were initially 
poorly crystalline and gradually converted into polycrystalline mineral particles. EDX analysis suggested that the 
particles consist of calcium phosphate containing minor additional elements (G & N).
future science group
Nanoparticle conversion to biofilms using serum-derived mineralo-organic nanoparticles    Research Article
matrix also represent a topic worthy of further stud-
ies as seen by the observation that extracellular matrix 
proteins control the formation of calcium phosphate 
particles during bone and tooth formation [47], and 
these proteins may also play a role in ectopic calcifi-
cation. Further studies are needed to examine these 
phenomena in more detail.
A previous study by Schwartz et al. examined the 
effects of various biochemical treatments on the forma-
tion of mineral biofilms derived from calcified human 
samples [48]. This study showed that RNAse failed to 
influence biofilm formation while the antibiotic drugs 
gentamycin and tetracycline completely inhibited this 
process [48]. In addition, the same study showed that 
mineral biofilms stained with concanavalin A (a carbo-
hydrate-binding protein or lectin) and BacLight green 
(a commercial kit used to differentiate living bacteria 
from dead ones). While such results give the impres-
sion that living and enzymatic processes are necessary 
for the formation of mineral NPs and biofilms, we have 
shown here that mineralized biofilms can be derived 
from the precipitation of inorganic mineral NPs in 
the presence of organic molecules derived from body 
fluids. This conclusion is consistent with our previous 
observations that NB and calcifying NPs represent 
non-living mineral NPs that mimic living organisms 
in various ways [14,18]. Accordingly, we have shown that 
the whole NB phenomenology can be re-interpreted 
in terms of the interactions between minerals and 
organic moieties found in body fluids [11,14,18]. This 
simple explanation can fully account for the observa-
tions of NB and calcifying NPs in the human body and 
biological fluids.
Conclusion
We have shown that mineralo-organic NPs similar to the 
particles described in human tissues differentiate to form 
mineral biofilms during incubation in biological fluids. 
The serum proteins albumin and fetuin-A are associated 
with all growth stages of mineralo-organic NPs derived 
from body fluids, especially with the electron-dense phase 
of the particles. These findings support the concept that 
the mineralo-organic NPs detected in human tissues may 
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Figure 9. Selected area electron diffraction analysis 
of mineralo-organic nanoparticles. Mineralo-organic 
NPs were prepared as in Figure 5, using either 1% FBS 
(A) or 10% HS (B). The particles were prepared for 
thin-section TEM and SAED analysis as described in 
the ‘Materials & methods’ section. Commercial HAP 
was analyzed in the same manner for comparison (C). 
Notice the presence of faint concentric rings showing 
a polycrystalline nanomaterial containing multiple 
crystals of relatively small sizes for FBS-NPs and HS-NPs, 
whereas commercial HAP produced an array of dots 
showing the presence of relatively large single crystals 
(with sizes averaging 100 ± 50 nm).
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Future perspective
The analyses and techniques described in the present 
study may be used to study the formation of mineralo-
organic NPs and to detect these particles in human tis-
sues. Our experimental system also provides an in vitro 
model for studying the formation of mineral deposits 
similar to the ones found in calcified human tissues. 
Besides, albumin and fetuin-A appear to represent appro-
priate markers for the detection of calcium phosphate 
NPs in human tissues. We expect that future studies will 
be performed to describe in more detail the formation of 
mineralo-organic NPs in the human body as well as their 
role in human health and disease.
Acknowledgements
The authors would like to thank Willisa Liou (Chang Gung Uni-
versity) and Mei-Chen Chiang (Ming Chi University of Technol-
ogy) for help with immunogold staining and EDX, respectively. 
We also thank Jyh-Ping Chen (Chang Gung University) and 
Chun-Chen Yang (Ming Chi University of Technology) for pro-
viding equipment and technical assistance for the DLS and AFM 
analyses, respectively. Acknowledgements are also due to Yu-
Hsiu Lee (Chang Gung University) for performing preliminary 
TEM observations related to this project.
Financial & competing interests disclosure
This study was supported by Primordia Institute of New Sciences 
and Medicine, and by grants from Chang Gung University (FM-
RPD2T02, EMRPD1A0961), from Ming Chi University of Technol-
ogy (0XB0) and from the National Science Council of Taiwan 
(101-2632-B-182-001-MY3). The authors have no other relevant 
affiliations or financial involvement with any organization or en-
tity with a financial interest in or financial conflict with the sub-
ject matter or materials discussed in the manuscript apart from 
those disclosed.
No writing assistance was utilized in the production of this 
manuscript.
Ethical conduct of research
The authors state that they have obtained appropriate institu-
tional review board approval or have followed the principles 
outlined in the Declaration of Helsinki for all human or animal 
experimental investigations. In addition, for investigations involv-
ing human subjects, informed consent has been obtained from 
the participants involved.
Open access
This work is licensed under the Attribution-NonCommer-
cial-NoDerivatives 4.0 Unported License. To view a copy of 









Figure 10. Powder X-ray diffraction analysis of mineralo-organic nanoparticle specimens. Mineralo-organic NPs 
were prepared as in Figure 5, using FBS at 1%. Particles were analyzed immediately after precipitation (A) or 
following incubation for 1 day (B), 1 week (C) and 1 month (D). Following incubation, the particles were prepared 
for XRD analysis as described in the ‘Materials & methods’ section. This XRD analysis showed that the amorphous 
particles obtained following precipitation in (A) gradually crystallized with time as seen with the diffraction peak 
observed in (B) and the multitude of peaks corresponding to HAP in (C) and (D).
future science group
Nanoparticle conversion to biofilms using serum-derived mineralo-organic nanoparticles    Research Article
Executive summary
Formation of mineralo-organic nanoparticles in biological fluids
•	 Mineral particles that precipitate in biological fluids form round amorphous nanoparticles (NPs) that gradually 
grow in size, aggregate and coalesce to form crystalline mineral biofilm-like structures.
•	 The mineral biofilm-like structures resemble mineral deposits observed in calcified human arteries and ectopic 
calcifications.
Localization of serum proteins in mineralo-organic NPs
•	 The serum proteins albumin and fetuin-A are associated with all growth stages of the mineral particles and 
are found within electron-dense areas.
Possible role of mineralo-organic NPs in the human body
•	 Mineralo-organic NPs detected in human tissues may represent precursors that evolve to form crystalline 
mineral deposits similar to the ones found in mineralized tissues and ectopic calcification.
Future perspective
•	 The experimental methodology employed here may be used to study the process of ectopic calcification 
occurring in human body fluids and soft tissues.
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